Report Highlights

Membrane Separation Materials in the U.S.: Market Overview

The U.S. membrane separation materials market was valued at USD 2.14 billion in 2024 and is forecast to reach USD 3.47 billion by 2032, expanding at a 6.2% CAGR. Demand is distributed across municipal water and wastewater treatment, semiconductor ultrapure water systems, biopharmaceutical sterile filtration, and industrial separations in food, chemicals, and hydrogen. Polymeric membranes account for most unit volume, while ceramic and specialty membranes command higher value in biopharma and high-temperature applications.

Policy has shaped this market's structure more than market forces alone. The Safe Drinking Water Act of 1974, enforced by the U.S. Environmental Protection Agency's Office of Water, created the compliance floor that drove municipal adoption of reverse osmosis and nanofiltration. Government has been the dominant buyer through state revolving funds, whereas private manufacturers including Toray Industries, DuPont, and Nitto Denko's Hydranautics have led product innovation, membrane chemistry, and domestic manufacturing scale-up.

Policy-Driven Growth in U.S. Membrane Separation Materials

The Inflation Reduction Act of 2022 created the Clean Hydrogen Production Credit under Section 45V of the Internal Revenue Code, worth up to USD 3.00 per kilogram for hydrogen produced below 0.45 kg CO2e per kilogram. Electrolyzers using proton exchange membrane and anion exchange membrane stacks qualify, so each qualifying project generates direct demand for membrane materials. Treasury's final 45V regulations in January 2025 locked in the lifecycle emissions framework that makes these membrane purchases bankable.

The CHIPS and Science Act of 2022 authorized USD 39 billion in manufacturing incentives administered by the Commerce Department's CHIPS Program Office, which supports new fabrication plants. Each advanced fab requires ultrapure water loops built on reverse osmosis, ultrafiltration, and electrodeionization membranes, so every incentive-backed fab converts directly into membrane demand. Under the Bipartisan Infrastructure Law of 2021, Congress allocated USD 5 billion for emerging contaminants including PFAS through the Drinking Water State Revolving Fund, funding treatment upgrades that favor nanofiltration and reverse osmosis.

Regulatory Barriers and Compliance Costs

The Build America, Buy America Act requires SRF-funded projects to use manufactured products with domestic content meeting OMB thresholds, currently 55 percent of component cost in 2024 and rising to 75 percent by 2029. The Office of Management and Budget sets these thresholds while EPA's SRF program enforces them, so imported membrane elements must be requalified or excluded. Section 232 steel tariffs, raised to 50 percent in June 2025 by the Commerce Department's Bureau of Industry and Security, further lift the cost of stainless steel pressure vessels.

FDA's current Good Manufacturing Practice regulations under 21 CFR Parts 210 and 211 require sterilizing-grade membrane filters used in biologics to be validated for each product, adding extractables and leachables testing to every qualification cycle. Validation typically consumes nine to twelve months before a new membrane supplier is approved. EPA's PFAS National Primary Drinking Water Regulation, finalized in April 2024, sets maximum contaminant levels of 4 parts per trillion for PFOA and PFOS, and state primacy agencies then issue permits that add further approval time.

Policy-Created Opportunities in U.S. Membrane Separation

EPA's PFAS rule and the Bipartisan Infrastructure Law's emerging contaminants allocation create a procurement pipeline for nanofiltration and reverse osmosis systems in utilities across states with high PFAS detections, including New Jersey and North Carolina. Utilities that secure SRF loans with principal forgiveness can procure membrane modules directly, shortening the sales cycle for suppliers able to offer domestically manufactured elements. Membrane suppliers with U.S. fabrication lines are positioned to capture this demand first.

The CHIPS Act's incentives create a second opportunity in ultrapure water membranes for fabs in Arizona, Ohio, and Texas, where TSMC and Intel require high-recovery reverse osmosis and electrodeionization modules. Separately, the Section 45V credit and DOE's ARCHES hydrogen hub in California and HyVelocity hub on the Gulf Coast, two of seven hubs selected in 2023 under the IIJA, create demand for proton exchange and anion exchange membranes. Replacement cycles generate recurring revenue beyond initial equipment sales.

Market at a Glance

Leading Market Participants

• Toray Industries
• DuPont de Nemours
• Dow Inc.
• Nitto Denko (Hydranautics)
• Koch Separation Solutions
• Danaher (Pall Corporation)
• MilliporeSigma
• Entegris
• Pentair
• Xylem

Regulatory and Policy Environment

The primary legislation is the Safe Drinking Water Act, 42 U.S.C. §300f et seq., administered by EPA's Office of Water, with its PFAS National Primary Drinking Water Regulation published in April 2024. EPA's May 2025 decision retains enforceable MCLs of 4 ppt for PFOA and PFOS, extends compliance to 2031, and moves to rescind limits for PFHxS, PFNA, HFPO-DA, and the hazard index mixture. The Toxic Substances Control Act, administered by EPA's Office of Chemical Safety and Pollution Prevention, requires PFAS manufacturers and importers to report under Section 8(a)(7), with the reporting window scheduled for 2026.

Compared with regional peers, the U.S. sets enforceable federal limits on fewer PFAS compounds than the European Union, whose Drinking Water Directive (EU) 2020/2184 introduces a 0.1 microgram per litre sum limit for 20 PFAS compounds from January 2026. Canada addresses PFAS through the Canadian Environmental Protection Act, 1999, using Section 71 notices, and has no binding drinking water limit covering the full PFAS group. The U.S. framework is therefore narrower in scope but more prescriptive in procurement, with Build America, Buy America and the 45V rules shaping sourcing decisions.

Long-Term Policy Outlook for U.S. Membrane Separation Materials

By 2031, the PFAS compliance deadline will convert current utility planning into construction contracts, with nanofiltration and reverse osmosis capacity in demand across SRF-funded systems. Congress has not enacted federal PFAS liability relief, so utilities will continue procuring membrane systems under the existing Safe Drinking Water Act framework. The July 2025 reconciliation law, the One Big Beautiful Bill Act, restricts 45V eligibility to projects beginning construction before January 1, 2028, compressing electrolyzer membrane orders into the 2026 to 2027 window.

Build America, Buy America domestic content thresholds reaching 75 percent in 2029 will reshape supplier selection, favoring manufacturers that localize polymer casting, module assembly, and element winding in the United States. EPA's commitment to rescind four PFAS limits and the hazard index mixture will require new rulemaking, generating further monitoring obligations in the early 2030s. Suppliers that localize production before 2029 will hold pricing power in the SRF market, while importers face requalification costs that exclude them from most federally funded projects.